Literature DB >> 16684268

Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis.

Stefan Odenbreit1, Stefan Linder, Bettina Gebert-Vogl, Gabriele Rieder, Anthony P Moran, Rainer Haas.   

Abstract

BACKGROUND: The colonization of the gastric mucosa with Helicobacter pylori is accompanied by elevated levels of proinflammatory cytokines, such as interleukin-1 (IL-1), IL-6, and IL-8. The aim of our study was to determine the mechanisms of IL-6 stimulation in phagocytes upon H. pylori infection.
MATERIALS AND METHODS: We investigated the secretion of IL-6 by different professional phagocytes from murine and human origin, including granulocyte- and monocyte-like cells and macrophages derived from human peripheral blood monocytes (PBMCs). The influence of viability, phagocytosis, and the impact of different subcellular fractions of H. pylori bacteria were evaluated.
RESULTS: IL-6 levels induced by H. pylori were low in cell lines derived from murine and human monocytes and in human granulocyte-like cells. By contrast, macrophages derived from human PBMCs were highly responsive to both H. pylori and Escherichia coli. IL-6 induction was blocked by inhibition of actin-dependent processes prior to infection with H. pylori, but not with E. coli or E. coli lipopolysaccharide (LPS). Using cell fractionation, the most activity was found in the H. pylori membrane. H. pylori LPS exhibited a 10(3)- to 10(4)-fold lower biologic activity than E. coli LPS, suggesting a minor role for toll-like receptor 4 (TLR4)-mediated signalling from the exterior.
CONCLUSIONS: From these data, we conclude that macrophages may be a major source of IL-6 in the gastric mucosa upon H. pylori infection. The IL-6 induction by H. pylori in these cells is a multifactorial process, which requires the uptake and presumably degradation of H. pylori bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684268     DOI: 10.1111/j.1523-5378.2006.00400.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes.

Authors:  Michael Fehlings; Lea Drobbe; Verena Moos; Pablo Renner Viveros; Jana Hagen; Macarena Beigier-Bompadre; Ervinna Pang; Elena Belogolova; Yuri Churin; Thomas Schneider; Thomas F Meyer; Toni Aebischer; Ralf Ignatius
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

2.  Notch Signaling Ligand Jagged1 Enhances Macrophage-Mediated Response to Helicobacter pylori.

Authors:  Junjie Wen; Chuxi Chen; Meiqun Luo; Xiaocong Liu; Jiading Guo; Tingting Wei; Xinyi Gu; Sinan Gu; Yunshan Ning; Yan Li
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

3.  Regulation of RKIP function by Helicobacter pylori in gastric cancer.

Authors:  Erika L Moen; Sicheng Wen; Talha Anwar; Sam Cross-Knorr; Kate Brilliant; Faith Birnbaum; Sherida Rahaman; John M Sedivy; Steven F Moss; Devasis Chatterjee
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

4.  rs744166 polymorphism of the STAT3 gene is associated with risk of gastric cancer in a Chinese population.

Authors:  Kexin Yuan; Huimin Liu; Lina Huang; Xiyun Ren; Jingjing Liu; Xiaoqun Dong; Wenjing Tian; Yunhe Jia
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

5.  Correlation Between Mucosal IL-6 mRNA Expression Level and Virulence Factors of Helicobacter pylori in Iranian Adult Patients With Chronic Gastritis.

Authors:  Fatemeh Azadegan-Dehkordi; Nader Bagheri; Mahsa Shirzad; Mohammad Hossein Sanei; Morteza Hashemzadeh-Chaleshtori; Mahmoud Rafieian-Kopaei; Mohammad Amin Tabatabaiefar; Hedayatollah Shirzad
Journal:  Jundishapur J Microbiol       Date:  2015-08-29       Impact factor: 0.747

6.  IL-23 Contributes to Control of Chronic Helicobacter Pylori Infection and the Development of T Helper Responses in a Mouse Model.

Authors:  Dennis J Horvath; M Kay Washington; Vicki A Cope; Holly M Scott Algood
Journal:  Front Immunol       Date:  2012-03-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.